SDC1 and Miyoshi myopathy: Bone marrow biopsy samples from MM patients demonstrate that SHH is mainly secreted by malignant CD138+ terminally-differentiated plasma cells, utilizing type III paracrine Hh signaling, to promote proliferation and the inhibition of chemotherapy-induced apoptosis [162].